Interviews with Hugues Berry and Sahar Barjesteh van Waalwijk van Doorn-Khosrovani.
Loic Verlingue from Centre Leon Berard has interviewed Hugues Berry, deputy scientific director for digital biology and digital health at Inria, National Institute for Research in Digital Science and Technology, France about the application of artificial intelligence in digital health. This episode is available both in English and French.
In episode 2 and 3, we meet Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, PhD and Pharmacist, Medicine & Society at CZ Health Insurance and Member of the National Payer’s Evaluation Committee for Specialized Medicines and Companion Diagnostics (CieBAG). This committee decides on the reimbursement of medicines and molecular diagnostics in The Netherlands. Furthermore, she is affiliated with Leiden University Medical Center. In episode 2, Sahar talks about pragmatic reimbursement in DRUP-like clinical trials and in episode 3, access and funding of Molecular Tumor Boards are addressed, using The Netherlands as an example.
Missed any updates or just exploring? Take a look through our archive!
Combining expertise across boarders to implement equitable and sustainable precision cancer medicine
The PCM4EU Spring Academy - Upcoming event in Porto, Portugal, April 2024.
New podcast episodes focusing on cross-boarder access to clinical trials available.